License and Joint Development Agreement on NC-6300/K-912 with KowaLicense and Joint Development Agreement • October 21st, 2016
Contract Type FiledOctober 21st, 2016On October 21, 2016, NanoCarrier accepted the proposal from Kowa Company, Ltd. (President & CEO: Yoshihiro Miwa; “Kowa”) to cancel the agreement on licensing for the exclusive manufacture and marketing and joint development of Epirubicin Micelle (NC-6300/K-912) worldwide originally executed on September 26, 2011.